Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Conditions: Angiosarcoma; Epithelioid Hemangioendothelioma Intervention: Drug: Eribulin Sponsors: Massachusetts General Hospital; Eisai Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials